N2 News

SOP’s Version 10!

The N2 SOP Committee will soon begin the review process in preparation for issuance of N2 SOPs Version 10.  The Committee will plan to meet monthly, starting this September through to February, 2023.  If you are interested in joining the Committee, please contact N2@n2canada.ca.

Launch of the Clinical Trials Fund Grant

The Canadian Institutes of Health Research (CIHR) has launched three grant calls under its Clinical Trials Fund (CTF). These grants aim to support clinical trials in three ways: platforms with the development of a pan-Canadian Clinical Trials Consortium; people with the funding of training platforms; and projects through the funding of a broad spectrum of clinical trial initiatives.

View grants here.

Please connect with us (n2@n2canada.ca) if you wish to discuss any potential partnerships with N2 on your Clinical Trials Fund applications.’

HRF Medal of Honour

Accepting Nominations until June 22nd, 2022.

Since its inception in 1945, the HRF Medal of Honour has been awarded to truly outstanding individuals whose research and/or contribution to public policies supportive of research and development in Canada have achieved international recognition.

Nominees must be Canadian residents whose work/research has been performed in Canada and has made a truly notable or pivotal contribution to the advancement of knowledge in the health sciences, health policy and/or the improvement of therapeutics and healthcare. Recipients can originate from a variety of fields and sectors including patient organizations, academia, media, industry, and the public and non-profit sectors.

The $20,000 prize will be invested into innovative health research at the Canadian academic institution of the recipient’s choice to promote further health and life sciences research in Canada.

To submit a nomination for a worthy candidate, please visit: www.hrf-frs.com

U.S. FDA and Health Canada will be co-hosting a regional public consultation

The U.S. FDA and Health Canada will be co-hosting a regional public consultation on Wednesday, May 11, 2022 from 1:00pm-4:00pm EDT to provide information and receive comments on current ICH working group activities and anticipated future topics. The purpose of the public meeting is to solicit input prior to the next International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) biannual Assembly and Management Committee meetings scheduled in May 2022. Links to the meeting registration and agenda have been posted on the ICH website.

For more information about ICH, please visit the ICH page on Canada.ca or contact the ICH coordinator inbox at ich@hc-sc.gc.ca.